Risks of testosterone-replacement therapy and recommendations for monitoring

N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251.

Authors

Ernani Luis Rhoden¹, Abraham Morgentaler

Affiliation

¹ Division of Urology, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, USA.

PMID: 14749457
DOI: 10.1056/NEJMra022251

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Age Distribution
Cardiovascular Diseases / etiology
Drug Monitoring / methods
Hormone Replacement Therapy / adverse effects*
Humans
Hypogonadism / drug therapy*
Lipids / blood
Male
Polycythemia / chemically induced
Prostate-Specific Antigen / blood
Prostatic Diseases / chemically induced
Risk Factors
Testosterone / administration & dosage
Testosterone / adverse effects
Testosterone / deficiency
Testosterone / therapeutic use*

Substances

Lipids
Testosterone
Prostate-Specific Antigen